Peptides
Novus Biologicals™ FKBP52/FKBP4 Recombinant Protein Antigen
Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
ProSci ULK4 Peptide
Used for Blocking Activity
ProSci FKBP4 Peptide
Used for Blocking Activity
Enzo Life Sciences Chaetomellic acid A (5mg). CAS: 148796-51-4
Potent inhibitor of farnesyltransferase in isolated enzyme assays (IC50=55nM) but is inactive in whole cells. Inhibition of farnesyltransferase is selective over geranylgeranyltransferase I and II (IC50=92µM and 34µM respectively). Purity: ≥98% (TLC). Solubility: Soluble in warm water (2mg/ml, slightly cloudy). Long Term Storage: -20°C.
Carbosynth LLC. Pyr-Arg-Thr-Lys-Arg-MCA (5 mg vial), 1ea, MW: 827.929999999999, Molecular formula: C37H57N13O9, CAS# 155575-02-3
This item has a minimum order quantity of 2 per supplier requirements
Synonyms: L-Pyroglutamyl-L-Arginyl-L-Threonyl-L-Lysyl-L-Arginine 4-Methyl-Coumaryl-7-Amide, pERTKR-aminomethylcoumarin, pERTKR-AMC, pERTKR-MCA, Pyr-Arg-Thr-Lys-Arg-AMC, pyroGlutamate-Arginine-Threonine-Lysine-Arginine-aminomethylcoumarin, Purity: , Grade A, Application: Substrate for Furin, Storage Temperature: -20C, References: K. Hatsuzawa, M. Nagahama, S. Takahashi, K. Takada, K. Murakami, and K. Nakayama, J. Biol. Chem., 267, 16094 (1992)., E.H. Blanco et al, Endo, 156, 3625 (2015)., I. Lindberg & J.R. Appel, Methods Mol Biol., 768, 155 (2011).
CPC Scientific H-Gly-Tyr-Pro-Gly-Gln-Val-NH2
(trifluoroacetate salt) 25MG
Tethered ligand sequence of human PAR-4.SEQUENCE: H-Gly-Tyr-Pro-Gly-Gln-Val-NH2(trifluoroacetate salt)ONE-LETTER SEQUENCE: GYPGQV-NH2MOLECULAR FORMULA: C28H42N8O8MOLECULAR WEIGHT: 618.69STORAGE CONDITIONS: -20 5 CCAS REGISTRY NUMBER: [245443-51-0]SYNONYMS: Proteinase Activated Receptor 4 (1-6) amide (human), GYPGQVamide, Coagulation Factor II Receptor-Like 3 (1-6) amide (human), Thrombin Receptor-Like 3 (1-6) amide (human), GYPGQV-NH2 Selective Protease-Activated Receptor 4 (PAR4) AgonistRESEARCH AREA: HematologyREFERENCES:M.D.Hollenberg et al., Can. J. Physiol. Pharmacol., 77, 458 (1999)M.Tognetto et al., Br. J. Pharmacol., 139, 21 (2003)M.D.Hollenberg and S.Houle, Swiss Med. Wkly., 135, 425 (2005)SKU(s): PARP-013A, PARP-013B
CPC Scientific H-Ile-Met-Gln-Val-Pro-Phe-Ser-Val-OH (trifluoroacetate salt) 1MG
Peptide that contains modified sequence of the gp 100 epitope gp(209-217), in which a methionine replaced the natural threonine at position 2. This peptide also binds to the HLA-A2 molecule with greater affinity than the unmodified peptide and has exhibited a good ability to stimulate melonomareactive cytotoxic T lymphocytes (CTLs) in vitro when used for sensitization of peripheral blood mononuclear cells. This synthetic peptide holds promise for the development of novel cancer immunotherapies.ONE-LETTER SEQUENCE: IMQVPFSVMOLECULAR FORMULA: C43H69N9O11S1MOLECULAR WEIGHT:920.13STORAGE CONDITIONS: -20 5C, CAS REGISTRY NUMBER: [255710-51-1], RESEARCH AREA: CancerREFERENCES: S.A. Rosenberg et al., Nature Med., 4, 321 (1998)